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Abstract: Free-energy changes are essential physicochemical quantities for understanding most
biochemical processes. Yet, the application of accurate thermodynamic-integration (TI) computa-
tion to biological and macromolecular systems is limited by ﬁnite-sampling artifacts. In this paper,
we employ independent-trajectories thermodynamic-integration (IT-TI) computation to estimate
improved free-energy changes and their uncertainties for (bio)molecular systems. IT-TI aids
sampling statistics of the thermodynamic macrostates for ﬂexible associating partners by
ensemble averaging of multiple, independent simulation trajectories. We study peramivir (PVR)
inhibition of the H5N1 avian inﬂuenza virus neuraminidase ﬂexible receptor (N1). Binding site
loops 150 and 119 are highly mobile, as revealed by N1-PVR 20-ns molecular dynamics. Due
to such heterogeneous sampling, standard TI binding free-energy estimates span a rather large
free-energy range, from a 19% underestimation to a 29% overestimation of the experimental
reference value (-62.2 ( 1.8 kJ mol-1). Remarkably, our IT-TI binding free-energy estimate
(-61.1 ( 5.4 kJ mol-1) agrees with a 2% relative difference. In addition, IT-TI runs provide a
statistics-based free-energy uncertainty for the process of interest. Using ∼800 ns of overall
sampling, we investigate N1-PVR binding determinants by IT-TI alchemical modiﬁcations of
PVR moieties. These results emphasize the dominant electrostatic contribution, particularly
through the N1 E277-PVR guanidinium interaction. Future drug development may be also guided
by properly tuning ligand ﬂexibility and hydrophobicity. IT-TI will allow estimation of relative free
energies for systems of increasing size, with improved reliability by employing large-scale
distributed computing.
Introduction
The free-energy change upon binding is the fundamental
thermodynamic quantity to evaluate inhibitor afﬁnity for
a target protein. Reliable free-energy changes can be
estimated by computer simulations via thermodynamic-
integration (TI) methods.
1-5 In practice, such calculations
are highly accurate for small compounds within the force
ﬁeld and model resolution employed.
6,7 In principle, TI
approaches should also provide accurate binding free
energies for large biological systems.
8,9 However, TI
approaches require a sufﬁcient sampling of the phase-space
regions where the Hamiltonians corresponding to two
states of the system differ signiﬁcantly.
1,10,11 Therefore,
the practical use of TI-based approaches in the context of
macromolecular processes is still rather limited.
* Corresponding author phone: +1-858-534-2913; e-mail: rbaron@
mccammon.ucsd.edu.
† Department of Chemistry & Biochemistry.
‡ Center for Theoretical Biological Physics.
§ Department of Pharmacology.
| Howard Hughes Medical Institute.
J. Chem. Theory Comput. 2009, 5, 1106–1116 1106
10.1021/ct800559d CCC: $40.75  2009 American Chemical Society
Published on Web 03/25/2009Finite sampling problems for a given equilibrium ther-
modynamic state can be alleviated by multiple independent
simulations.
12-14 This enhances phase-space sampling and
allows distribution of the computation into a number of
independent runs, which is particularly appealing in consid-
eration of the rapid and steady increase of computational
power in the form of multiple CPU clusters vs single CPU
supercomputers (e.g., http://www.sdsc.edu; http://www.nccs.
gov; http://www.bsc.es).
Here, we present the independent-trajectories thermody-
namic-integration (IT-TI) approach to calculate free-energy
changes for (bio)molecular systems. IT-TI employs multiple,
independent TI calculations to calculate a free-energy change
of interest, while incorporating both soft-core potentials
15,16
and ligand translational restraints
17,18 to effectively improve
the extent of phase-space accessed. Our results show that
IT-TI allows signiﬁcantly increased accuracy compared with
standard TI. Using IT-TI in the context of protein-ligand
binding and macromolecular association seems particularly
motivated for highly ﬂexible binding partners. This is the
case for the H5N1 avian inﬂuenza neuraminidase receptor
studied in this work (Figures 1 and 2).
The avian inﬂuenza virus type A, particularly its H5N1
form, is becoming a worldwide pandemic threat due to its
high virulence and lethality in birds, rapidly expanding host
reservoir, and exceptionally elevated mutation rate (http://
www.who.int/csr/disease/avian_inﬂuenza). Extraordinary re-
search efforts are devoted to understanding the molecular
basis of inhibitor susceptibility to avian inﬂuenza viral
enzyme neuraminidase (NA) mutations, particularly for the
lethal and drug-resistant group 1 NA enzymes that include
H5N1.
19-21 The inhibitor peramivir (PVR, also known as
BCX-1812 or RWJ-270201; developed by BioCryst Phar-
maceuticals, Birmingham, AL; see Scheme 1) is demon-
strated to be active in vitro and in vivo against both group
1 and 2 viral NA.
22,23 Therefore, PVR constitutes a promising
candidate for further drug-design research.
24
In this paper, we explore the changes of conformational
dynamics and hydration of PVR upon binding to avian
inﬂuenza virus H5N1 NA (Figure 1). We perform IT-TI
calculations that yield an accurate estimate for the N1-PVR
free energy of binding, within ∼1k Jm o l -1 of experiment.
Then, we investigate N1-PVR binding determinants and
quantify their thermodynamic role in the binding process
through IT-TI alchemical modiﬁcations of selected PVR
moieties. This work represents a ﬁrst step in the computer-
based development of a putative novel class of N1 inhibitors
from accurate free-energy calculations. We anticipate that
IT-TI will allow, in general, the estimation of relative free
energies for systems of increasing size, with improved
reliability, by employing large-scale distributed computing.
25
Materials and Methods
Molecular Models. The initial coordinates for the N1
neuraminidase monomer bound to the PVR inhibitor (N1-
PVR) were taken from the X-ray crystal structure
26 of N1
bound to oseltamivir (PDB ID: 2HU4; chain A), because no
N1-PVR structure has been deposited to date. Atom posi-
tional coordinates for PVR were taken from the correspond-
ing N8-PVR structure
26 (PDB ID: 2HTU; chain A) and
superimposed onto 2HU4 using the protein backbone CR
Figure 1. The avian inﬂuenza virus N1 neuraminidase protein receptor and its PVR binding site. (a) N1-PVR model structure
and scaffold structures containing important PVR-binding residues (green,  -sheet 406; red,  -turn 277; orange,  -turn 222;
pink, loop 119; blue, loop 150). (b) Close up of the N1-PVR binding site with key residues highlighted.
Figure 2. Time series of the CR atom-positional root-mean-
square deviation (rmsd) of each N1-PVR binding site loop or
secondary structure element from the X-ray structure. Color
code as in Figure 1. Running averages over 20-ps windows
are used for graphical purposes.
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PVR ring atoms. The N1-PVR complex was solvated in (pre-
equilibrated) cubic boxes large enough (∼8.3 nm3) to avoid
any interactions between mirror images under rectangular
periodic boundary conditions. Three randomly chosen water
molecules (minimum ion-ion distances of 1.0 nm) were
replaced with Na+ ions to neutralize the system. Initial
conﬁgurations for the water (wt-PVR) and vacuum (vc-PVR)
reference states were deﬁned using the same PVR coordi-
nates. For a summary of N1-PVR, wt-PVR, and vc-PVR
simulated systems, see Table 1.
Molecular Dynamics Simulations. All simulations were
performed using the GROMOS05 software for biomolecular
simulation
27 and the GROMOS force ﬁeld
28 (45A3 parameter
set
7). Amino acid charges were deﬁned to reproduce an apparent
pH 7. GROMOS PVR force-ﬁeld parameters were derived from
existing building blocks
28-30 (Supporting Information, Table
S1). The GROMOS compatible SPC water model
31 and
previously reported SPC-water compatible parameters for ions
32
were employed. For ligand simulations in vacuo (vc-PVR) the
corresponding 45B3 parameter set was employed.
For N1-PVR, a ﬁrst steepest-descent energy minimization
(EM) was performed to relax solvent and ions, while protein
atom positions were restrained by using a harmonic potential
(force constant k ) 2.5 × 103 kJ mol-1 nm-2). A second
EM run without restraints eliminated any residual strain. All
EM runs were extended until the energy change per step
became <0.5 kJ mol-1. The system was then brought to the
reference temperature (T ) 300 K) in six consecutive MD
periods of 25 ps (50 K increments). During the heating of
N1-PVR, protein atom positions were restrained with a
harmonic potential, using a k from 104 to 0 (decreased in
steps of 2.5 × 103 kJ mol-1 nm-2). In addition, four
independent MD runs were initialized by reassigning random
velocities from Maxwell-Boltzmann distributions at 5 K.
All ﬁve independent trajectories were extended (at least 2
ns) to reach equilibration of the separate system Hamiltonian
components. Independent trajectories for the wt-PVR and
vc-PVR systems were similarly prepared. One MD run for
each system was extended for 20 ns and used for confor-
mational analysis (see below).
Newton’s equations of motion were integrated using the
leapfrog algorithm
33 with a 2-fs time step. The SHAKE
algorithm
34 was applied to constrain all bond lengths (relative
geometric tolerance of 10-4). All simulations were carried out
in the N,p,T ensemble (reference pressure 1 atm) by separately
coupling the temperature of solute and solvent degrees of
freedom to a 300 K heat bath
35 (relaxation time 0.1 ps) and by
coupling the pressure (estimated based on an atomic virial) to
Scheme 1. Summary of the Modiﬁcation Perturbations (COO-,N R 3
+, TAIL1, and TAIL1) for PVR Molecule
a
a The IT-TI free-energy changes due to PVR hydration ∆G j
hydr(L) and N1-PVR binding ∆G j
bind(L) are shown as well as PVR alchemical
modiﬁcation ∆∆G j
hydr(L*) and ∆∆G j
bind(L*). All values are given in kJ mol-1 with corresponding σ∆G j uncertainties between parentheses.
Table 1. System Setup for MD Simulations of PVR Bound
to the N1 Active Site (N1-PVR), Free in Water (wt-PVR),
and in Vacuum (vc-PVR)
N1-PVR wt-PVR vc-PVR
T [K] 300 300 300
no. Na+ ions 3 0 0
total system charge [e] 0 0 0
no. solute atoms 3863 30 30
no. water molecules 17046 1748 0
no. atoms in system 55004 5274 30
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35 via isotropic coordinate scaling [relaxation
time 0.5 ps; isothermal compressibility 4.574 × 10-4 (kJ mol-1
nm-3)-1]. Nonbonded interactions in the range 0.0-0.8 nm were
recalculated every time step and in the range 0.8-1.4 nm every
ﬁve time steps and truncated at 1.4 nm. A reaction-ﬁeld
correction was applied to account for the neglected interactions
beyond 1.4 nm,
36 using a relative dielectric permittivity of 61
for the SPC water model.
37 A fast grid-based pairlist-construc-
tion algorithm
38 was employed (cell-mask edge of 0.4 nm;
atomic-level cutoff) as implemented in the GROMOS05
MD++ module.
27
Conformational Analysis. Trajectory snapshots were
extracted every 2 ps from the 20-ns simulations. Structural
ﬁtting was performed by (i) superimposing solute centers of
mass (to remove overall translation) and (ii) performing an
atom-positional least-squares ﬁtting procedure
39 (to remove
overall rotation) using N1 CR atoms or all PVR atoms.
Transient N1-PVR interactions identiﬁed as important bind-
ing motifs were monitored using the GROMOS++ analysis
software.
27 Hydrogen bonds were deﬁned to have a maxi-
mum hydrogen-acceptor distance of 0.3 nm and a minimum
donor-hydrogen-acceptor angle of 125°. An extended hy-
drogen bond criterion was used (0.35 nm; 120°) to capture
additional relevant interactions. Salt bridges and hydrophobic
contacts were considered formed for atom pair distances
<0.45 nm. Secondary structure elements were deﬁned by the
following N1 residue sequences: loop 119, V116-P120; loop
150, T148-S153; loop 277, I222-E227;  -turn 277,
H274-C278; -turn292,V290-N294;loop347,G345-K350;
loop 371, S368-G373;  -sheet 406, S404-G408; loop 430,
R430-W438.
Independent-Trajectories Thermodynamic-Integra-
tion Method. The free-energy change between two states
A and B can be estimated by thermodynamic integration (TI)
as
40
where H(λ) denotes the system Hamiltonian from a single
trajectory as a function of the coupling parameter λ and 〈 ...〉
denotes ensemble averaging at a given λ value.
In IT-TI, Hi(λ) is the system Hamiltonian for the ith
independent trajectory, and the mean free-energy change
∆G j
AfB reads
where the integration runs over N independent trajectories.
In principle, under the assumptions of (i) inﬁnitely long
trajectories and (ii) a fully accessible system phase space,
eq 1 will provide an estimate of the free-energy change
between two states A and B which is identical to that
provided by eq 2. This follows in the limits of validity of
the ergodic hypothesis. In practice, however, due to the fact
that (i) only ﬁnite simulation times can be achieved and (ii)
the phase space of a solvated macromolecule is far from
being fully accessible (i.e., its corresponding free-energy
landscape is a very rough and frustrated surface at standard/
physiological conditions), eqs 1 and 2 provide signiﬁcantly
different free energy estimates (see Results and Discussion).
IT-TI overcomes this practical limitation by enhancing phase-
space sampling of the thermodynamic systems of interest,
therefore adding to the reliability and predictive power of
free-energy calculations.
Two types of thermodynamic perturbations AfB were
performed in this study, alternatively employing eq 1 or 2:
(i) from ligand L full potential (λ ) 0) to zero nonbonding
interactions (λ ) 1); (ii) from the L full potential (λ ) 0) to
that of a chemically modiﬁed ligand L* (λ ) 1); see Scheme
2. In both cases, soft-core interaction potentials
16 were used
for L atoms involved in the perturbation (sLJ ) 0.5 and sC )
0.5)
27,28 to avoid singularities and to enhance phase-space
sampling. Equations 1 and 2 were integrated numerically
using the trapezoidal rule.
Scheme 2. Thermodynamic Cycles: Annihilation Perturbation
a and Modiﬁcation Perturbation
b
a The binding free energy ∆G j
bind(L) for ligand L can be estimated by an annihilation perturbation (λ ) 0 f λ ) 1) of the nonbonded ligand
interactions in the protein and water-solvated thermodynamic states.
b The impact on the binding free energy, ∆∆G j
bind(L*), for a ligand modiﬁcation
L* can be estimated by corresponding perturbations (L f L*) in both thermodynamic states. An additional cycle was employed to estimate
hydration free energies ∆Ghydr(L).
∆GAfB ) ∫ λA
λBdλ〈
∂H(λ)
∂λ 〉 λ
(1)
∆G j
AfB ) ∫ λA
λBdλ
∑
i)1
N 〈
∂Hi(λ)
∂λ 〉
λ
N
(2)
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statistical procedures were employed to evaluate the uncer-
tainty σ for ∆GAfB or ∆G j
AfB free-energy estimates.
First, a simulation standard error σsim(t) of the time-varying
Hamiltonian derivative at a given λ can be calculated as
with T being the total number of block averages
41 throughout
the single ith trajectory or all N concatenated independent
trajectories. (∂Ht(λ)/∂λ)λ denotes the Hamiltonian derivative,
block-averaged at time t, and 〈 ∂HT(λ)/∂λ〉 λ is the ensemble
average over the entire simulation time at a given λ.A sa n
example, σsim(t) uncertainties are reported as error bars for
〈 ∂HT(λ)/∂λ〉 λ vs λ in Figure 3 (solid black curve). Then, a
corresponding free-energy uncertainty can be obtained as
This follows from the standard assumption that (∂Ht(λ)/
∂λ)λ values are statistically uncorrelated along the time over
different values of the coupling parameter λ. However, the
σ∆Gi uncertainty includes the physically based ﬂuctuations
of (∂Ht(λ)/∂λ)λ, though corresponding noise is typically
reduced by block-averaging.
41 Therefore, despite its wide
use in the literature, σ∆Gi is a questionable measure of
uncertainty for a free-energy change of interest. For example,
considering that overlap of phase space at neighboring λ
values is a requirement for smooth 〈 ∂HT(λ)/∂λ〉 λ vs λ curves
(Figure 3), one could claim that (∂Ht(λ)/∂λ)λ time series are
statistically correlated. Nonetheless, the abovementioned
uncertainty deﬁned in eq 4 is representing the lowest possible
uncertainty for a free-energy-change estimate from standard
TI. Thus, it seems the fairest choice for this study comparing
TI vs IT-TI results.
Second, for IT-TI, a statistics-based uncertainty σ∆G j on a
given free-energy change ∆G j
AfB from eq 2 can be calculated
as the standard deviation from the mean (standard error) of
the N ∆Gi results
where σ∆G is the standard deviation of the free-energy change
over the N IT-TI trajectories employed. Importantly, σ∆G j has
a clear statistical validity,
42 because of its explicit dependence
on the repeated independent estimates.
Similarly, for a general overall free-energy change ∆G j
AfB,
calculated as the difference between two free-energy changes
∆G j
B and ∆G j
A, a corresponding uncertainty can be obtained
by propagating the respective uncertainties as
42
Then, the relative uncertainty for a given free-energy
change A f B reads
In this study, IT-TI runs were extended to obtain suf-
ﬁciently smooth curves of 〈 ∂Hi(λ)/∂λ〉 λ vs λ (Figure 3). IT-
TI trajectories were independently equilibrated (0.5 ns) for
each of the 26 λ points (from ﬁve initial equilibrated λ ) 0
conﬁgurations), followed by independent sampling periods
(0.5 ns) used for free-energy estimation. Increased sampling
(up to 2.5 ns) times were required in the ranges 0.12 e λ e
0.24 and 0.76 e λ e 0.92. A summary of these calculations
is given in Supporting Information, Table S2. All annihilation
and modiﬁcation perturbations fulﬁlled the criterion σ∆G j(%)
< 6%. Only N1-TAIL1 and N1-TAIL2 modiﬁcation per-
turbations had larger σ∆G j(%) values (up to 52%) due to the
corresponding small ∆G j
AfB values (Supporting Information,
Table S3).
Separation of Thermodynamic States. For ∆G j
N1(L)
(Scheme 2a), the potential U(rL) )- 1/2k
(rL - r0)2 was applied to harmonically restrain ligand
translation and ensure its sampling of a ﬁnite phase-space
volume VΙ. An optimal k value of 246.5 kJ mol-1 nm-2
was estimated from the ensemble-averaged L root-mean-
Figure 3. 〈 ∂H(λ)/∂λ〉 λ values and corresponding uncertainties
σsim(t)v sλ. (a) Annihilation of PVR in N1 binding site (∆G j
N1(L);
Scheme 2a). (b) Annihilation of PVR in water (∆G j
wt(L);
Scheme 2a). Black lines: average values over all N individual
trajectories. Gray lines: individual trajectory TI curves. Inset
panels highlight λ regions where IT-TI averages outperform
standard individual TI calculations.
σsim(t) )  
1
T - 1∑
t)1
T [(
∂Ht(λ)
∂λ )
λ
- 〈
∂HT(λ)
∂λ 〉
λ]
2
/√ T
(3)
σ∆Gi ) (∫ λA
λBσsim
2(t)d λ)
1/2
(4)
σ∆G j )
σ∆G
√ N
(5)
σ∆G j
AfB ) √ (σ∆G j
A)
2 + (σ∆G j
B)
2 (6)
σ∆G j
AfB(%) )
σ∆G j
AfB
∆G j
AfB
× 100 (7)
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theorem as
18
where rL is the position of L during 20-ns of unrestrained
simulation at λ ) 0, r0 is the initial position of L in the
pre-equilibrated starting conﬁguration, P(rL) is the 3-D
positional probability distribution of L, R is the molar gas
constant, and T ) 300 K. In this study, rL and r0 are the
instantaneous and initial positions of the PVR C4 ring
carbon.
The phase-space volume VΙ can be deﬁned as
18
where   ) 1/RT. Thus, the correction
17 to the restraining
potential bias for ∆G j
N1(L) in Scheme 2 reads
Results and Discussion
Conformational Analysis of the N1-PVR Binding
Site. Figure 1 shows the six-bladed  -propeller structure of
N1 neuraminidase bound to PVR and important active site
residues, monitored throughout 20 ns of N1-PVR MD
simulation. To investigate N1-PVR receptor ﬂexibility and
conformational changes, the CR atom-positional rmsd from
the X-ray crystal structure was monitored for the secondary
structure elements forming the N1-PVR binding site (Figure
2). Loop 150 deviates the most (up to ∼0.7 nm) to sample
stable open-loop conﬁgurations (∼0.5 units) throughout the
MD simulation (Figures 1 and 2, blue). This observation is
similar to that recently reported for both apo and oseltamivir-
bound N1 neuraminidase (up to ∼0.6 nm).
43 Additionally,
we ﬁnd that loop 119 demonstrates signiﬁcant ﬂexibility and
samples conformations with rmsd of ∼0.4 and ∼0.3 nm in
the N1-PVR complex (Figures 1 and 2, pink). The dynamics
of loops 150 and 119 in water indicate a signiﬁcant relaxation
from the crystal-packed conformation captured in X-ray
experiments. The  -sheet 406 and  -turns 277 and 222 show
comparatively lower rmsd deviations (0.1-0.3 nm) and
smaller ﬂuctuations on the 20-ns time scale.
Table 2 summarizes the N1-PVR intermolecular hydrogen
bonding. Scheme 1 deﬁnes PVR atom nomenclature. A
dominant multicenter hydrogen bond between N1 E277 and
the PVR guanidinium group is stable for the entire simulation
time, with PVR NR3 and NR1 atoms alternating as hydrogen
donors to E277 carboxyl oxygen atoms OE1 and OE2
(50-69% occurrences). E277 also transiently interacts with
the PVR methyl acetamide polar hydrogen (HP; 57%). Yet
another hydrogen bond (54%) is observed between the PVR
carboxyl oxygen (OD1) and the N1 Y406 hydroxyl (O-H).
Interestingly, the Y406 residue is homologous to other key
catalytic tyrosine residues found in the avian inﬂuenza virus
family of glycosidases (Carbohydrate Active Enzymes
database; http://www.cazy.org/). Thus, targeting Y406 could
be important for drug design, as suggested by a computa-
tional solvent mapping analysis.
44 An extended hydrogen
bond between N1 R152 on loop 150 and PVR (O-H group)
occurs for 44% of the simulation time (Table 2 and Figure
1) and contributes to the stability of open loop 150 ensemble
of conﬁgurations.
Figure 4 describes the conformational sampling of PVR
in the N1 binding site. N1 protein atoms that maintain strong
interactions with either (i) charged ligand moieties (salt
bridges) or (ii) hydrophobic groups (hydrophobic packing)
display distance probability distributions with one sharp,
high-intensity peak. Those residues experiencing varied
interactions have broader distributions and/or multiple peaks.
Throughout the 20-ns simulation, the PVR guanidinium
group (CR atom, Scheme 1) maintains a well-deﬁned salt-
bridging interaction with the N1 E277 carboxyl group (0.38
nm average distance). The broad distribution for the PVR
CR-N1 E119 distance (0.52 nm) and the doubly peaked
distribution for the PVR CR-N1 E227 distance (0.47 and
0.65 nm for ﬁrst and second peak) correspond to transient
〈 rmsd
2〉 ) 〈 (rL - r0)
2〉 ) ∫(rL - r0)
2P(rL)d rL ) 3RT
k
(8)
VI ) ∫ Vexp[- U(rL)] dr (9)
VI ) ∫ Vexp[
1
2RT
k(rL - r0)
2]dr ) (
2πRT
k )
3/2
(10)
∆G j
N1(L) ) ∫ λ)0
λ)1
dλ
∑
i)1
N 〈
∂Hi(λ)
∂λ 〉
λ
N
+ RT ln(CVΙ) (11)
Table 2. N1-PVR Intermolecular Hydrogen Bonds from 20
ns of Molecular Dynamics Simulation
a
donor acceptor occurrence (%)
PVR (NR3-HR3) E277 (OE1) 69
PVR (NR3-HR3) E277 (OE2) 69
PVR (NR1-HR1) E277 (OE1) 50
PVR (NR1HR1) E277 (OE2) 57
PVR (NP-HP) E277 (OE2) 57
Y406 (O-H) PVR (OD1) 54
R152 (NH2-H22)
b PVR (O5) 44
a PVR atom nomenclature as in Scheme 1. OE refers to
glutamate carboxyl, O-H to tyrosine hydroxyl, and NH2-H22 to
arginine guanidinium. All N1-PVR intermolecular hydrogen bonds
occurring >5% are shown.
b Using extended hydrogen-bonding
criterion. See also Materials and Methods.
Figure 4. Conformational sampling of PVR moieties in the
N1 neuraminidase binding site from 20-ns N1-PVR molecular
dynamics simulation. Distance pairs are labeled according to
the atoms monitored: PVR CR to N1 E277 (blue), E119
(green), and E227 (red) carboxyl group carbon; PVR CD to
N1 R118 (pink), R292 (yellow), and R371 (violet); PVR C11
to N1 I222 side chain carbon (black) and W178 aromatic ring
carbon (cyan). See Scheme 1 for PVR atom nomenclature.
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PVR guanidinium group.
Stable long-range interactions between PVR and the
arginine triad of R118, R371, and R292 residues (Figure 1)
are observed along our 20-ns N1-PVR simulation, with
distribution peaks at 0.68, 0.8, and 0.96 nm, respectively
(Figure 4). This triad of positively charged residues also
contributes to binding via the conserved ligand carboxyl
group in both the natural ligand, sialic acid, and other
synthetic neuraminidases inhibitors (e.g., DANA, oseltamivir,
and zanamivir).
26,45 Our results support the fundamental role
of R118 and R371 in N1-PVR binding. The distal position
of R292 indicates less reliance of PVR on this residue and
could account for the retained PVR afﬁnity for the N2
resistance mutation R292K.
23,46
The PVR aliphatic tail (Scheme 1) has been designed
45
to ﬁll a small hydrophobic subpocket, comprised of W178
and I222 residues, which is conserved among both group 1
and 2 NA (Figure 1). Our MD simulation conﬁrms that PVR
tail atoms interact with the branched I222 side chain (C11
peak at 0.40 nm average distance; Figure 4). The same PVR
tail atoms are also stably close to the W178 aromatic carbons
(C11 peak at 0.42 nm; Figure 4). These results highlight the
occurrence of important hydrophobic-packing interactions in
the N1 subpocket.
We note that the majority of the conserved residues
described above have been suggested to also participate in
key interactions between sialic acid and inhibitors DANA,
zanamivir, and oseltamivir, as well as PVR, in both group 1
and 2 NA receptors.
26,44-48
Changes of PVR Hydration upon N1 Binding. PVR
hydration and its changes upon N1 binding were also
analyzed. Figure 5 shows the radial distribution functions
(rdf) for water oxygen atoms from wt-PVR and N1-PVR
simulations. The PVR guanidinium group (CR atom; Scheme
1) undergoes ∼0.5 units decrease in its ﬁrst peak intensity
upon N1-PVR binding. We can explain this desolvation
effect by considering the tight interaction of this bulky,
positively charged PVR group with the negatively charged
N1 E277 carboxyl (Figure 4 and Table 2). Desolvation upon
N1 binding is also observed for the PVR aliphatic tail by
the intensity decrease of its ﬁrst solvation shell peaks (C10
and C11 atoms, ∼0.5-0.9 units; Figure 5). This is consistent
with the formation of more favorable interactions between
PVR and N1 residues I222 and W178.
A different hydration behavior can be noticed for the PVR
carboxyl group (CD atom), with a similar strong intensity
for its ﬁrst peak at ∼0.35 nm in both wt-PVR and N1-PVR
simulations. Its second peak intensity diminishes only
marginally upon N1-PVR binding (∼0.3 units). Thus, the
PVR carboxyl group is still solvated in the N1 binding site
by dynamic water molecules on an ensemble averaged basis.
The presence of water molecules in the N1-PVR binding
site and the lack of persistent ligand-solvent hydrogen bonds
conﬁrm this point. A PVR carboxyl group-N1 Y406
hydroxyl hydrogen bond is transiently formed (54% occur-
rence; Table 2), allowing this PVR moiety to still repeatedly
interact in the N1-PVR binding site with water molecules.
Water exchange in charged protein cavities
49 and water-
mediated interactions in ﬂexible carbohydrate-protein bind-
ing
50 have been previously reported.
The PVR hydroxyl group displays a ﬁrst peak with reduced
intensity when N1-bound (O5 atom, ∼0.5 units; Figure 5).
This moiety forms a competing hydrogen bond to N1 R152
(44%; Table 2), yet water molecules are maintained in the
ﬁrst solvation shell upon binding. The PVR acetamide group
(NP atom) has limited solvent accessibility due to the
adjacent hydrophobic tail. Its solvation is further decreased
(∼0.5 units) in the bound state upon formation of a hydrogen
bond to N1 E277 (57% occurrence; Table 2).
Overall, the interactions of the PVR guanidinium group
with N1 E277, E227, and E119; the PVR carboxyl group
with catalytic N1 Y406; and the PVR aliphatic tail with N1
W178 and I222 in the hydrophobic subpocket appear most
relevant to drive N1-PVR binding based on conformational
and hydration analyses.
IT-TI Free-Energy Change upon N1-PVR Binding. The
free-energy change upon N1-PVR binding was estimated
using the IT-TI method and compared with standard TI
values from single trajectories, as well as with experiment.
Examples of 〈 ∂Hi(λ)/∂λ〉 λ vs λ curves are shown for
standard TI and the improved IT-TI calculations of the N1
protein and water reference states (Figure 3). The IT-TI
curves are smoother than those obtained from individual
standard TI runs, because of increased sampling and im-
proved overall statistics obtained through N ) 5 independent
ensembles. Their integration (eq 2) provides ∆G j
wt(L) and
∆G j
N1(L) values to estimate ∆G j
bind (Supporting Information,
Table S3). This is summarized in the thermodynamic cycle
of Scheme 2a.
Table 3 reports the IT-TI results and their comparison with
the available experimental data. Our IT-TI ∆G j
bind estimate
(-61.1 ( 5.4 kJ mol-1) matches the ∆G j
bind
exp value derived
from multiple IC50 measurements
21,51,52 (-62.2 ( 1.8 kJ
mol-1; see Supporting Information, Table S4). A free-energy
difference of 1.1 kJ mol-1 (i.e., 2% relative difference) has
no statistical signiﬁcance within the above uncertainties.
Remarkably, such an IT-TI prediction of the experimental
value relies on individual ∆G j
bind(N) estimates that span a
rather large free-energy range (see Table 3). In fact, these
standard TI estimates are at variance with the independent
calculation performed, ranging from a substantial underes-
timation (i ) 4; 19% relative difference) to a substantial
overestimation (i ) 5; 29% relative difference) of the ∆G j
bind
exp
Figure 5. Ensemble-averaged solvation of PVR moieties
when free in solution (left panel) or bound to the N1 protein
binding site (right panel). Radial distribution functions of the
water oxygen atoms from 20-ns molecular dynamics simula-
tions are shown centered on PVR atoms CR (blue), C10
(black solid), C11 (black dashed), CD (red), O5 (green), and
NP (cyan). See Scheme 1 for PVR atom nomenclature.
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good agreement with the ∆G j
bind
exp value (-63.7 ( 11.0 kJ
mol-1, i ) 1; 2% relative difference). The remaining four
TI estimates have relative differences >9%. A signiﬁcantly
different N1-PVR binding free-energy estimate of -1180.9
( 31.8 kJ mol-1 has been reported based on MM-PBSA
calculations.
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The IT-TI free-energy estimate also has a lower σ∆G j(%)
relative uncertainty compared to the σ∆Gi(%) from standard
TI, i.e. 9% of the calculated free-energy difference (Table
3). σ∆Gi(%) values associated with independent ∆Gbind(N)
estimates are larger, ranging between 12% (i ) 4) and 19%
(i ) 5). We stress that the uncertainties σ∆Gi typically
evaluated for single standard TI trajectories are not statistical
indicators of the ∆Gbind accuracy (see Materials and Methods,
eq 4). Instead, repeated IT-TI runs allow calculation of the
more representative free-energy uncertainty σ∆G j (see Materi-
als and Methods, eq. 5). In addition, for this study, the latter
is directly comparable to the standard error of ∆G j
bind
exp
determined from N experimental values (Supporting Infor-
mation, Table S4).
Overall, our results underscore the improved predictive
power of IT-TI vs standard TI, due to the increased statistical
reliability. The large deviations observed among standard
TI estimates can be explained, in part, by the ﬂexibility of
the N1 binding site. Loops 119 and 150 demonstrate
heterogeneous conformational sampling among different λ
regions; their rmsd from the initial equilibrated structure
reach values up to 0.4 and 0.7 nm, respectively (data not
shown). This is consistent with both the dynamic loop
behavior from the longer 20-ns MD simulation (Figure 2)
and with the large σ∆Gi values for standard TI estimates
(Table 3). We conclude that the IT-TI method signiﬁcantly
aids sampling of thermodynamic macrostates for ﬂexible
receptors by ensemble averaging of independent trajectories.
IT-TI Free-Energy Changes for PVR Alchemical
Modiﬁcations. N1-PVR binding determinants were also
investigated using IT-TI free-energy changes upon computer
alchemical modiﬁcations and their underlying thermody-
namic cycle (Scheme 2b). Scheme 1 summarizes the cor-
responding ∆∆G j
bind values together with the PVR free energy
of binding ∆G j
bind. A positive or negative value of ∆∆G j
bind
indicates thermodynamically unfavorable or favorable al-
chemical modiﬁcations of the ligand L.
Neutralizing COO- and NR3
+ charges has large but
opposite effects on ligand binding (∆∆G j
bind of +55.1 ( 3.1
and -79.7 ( 4.2 kJ mol-1, respectively). The TAIL1 and
TAIL2 modiﬁcations both have small, favorable impacts on
ligand binding (∆∆G j
bind of -5.8 ( 2.4 and -1.5 ( 2.0 kJ
mol-1, respectively). To understand these results, one must
look at the effects on receptor-ligand interactions and ligand
hydration free-energy changes (∆∆G j
hydr) upon alchemical
perturbation. In other words, a given ∆∆G j
bind change can
arise from different compensating effects. For example, a
positive ∆∆G j
bind value may be driven by (i) unfavorable
(enthalpic or entropic) N1-ligand interactions, (ii) a more
favorable ∆∆G j
hydr, or (iii) a thermodynamically unfavorable
combination of the previous effects. Similarly, a negative
∆∆G j
bind value may be driven by (i) favorable (enthalpic or
entropic) N1-ligand interactions, (ii) a more unfavorable
∆∆G j
hydr, or (iii) a thermodynamically favorable combination
of the previous effects. In this section, we address the impact
of different IT-TI modiﬁcation perturbations on N1-ligand
binding; in the next section, we consider the ligand hydration
free energy. Both are needed to fully describe a given
∆∆G j
bind binding free-energy change.
Throughout the λ ) 0 f λ ) 1N 1 -COO- modiﬁcation
perturbation, R292 and R371 residues move on average apart
from the ligand scaffold. The closest arginine, R118, reduces
its average distance to the ligand CD atom (Supporting
Information, Figure S1a). The important ligand carboxyl-
Y406 interaction (Table 2) is partially disrupted, while
guanidinium interactions with E119, E227, and E277 are
maintained.
During the λ ) 0 f λ ) 1N 1 -NR3
+ modiﬁcation, N1
R371 samples a more stable conformation close to the ligand
CD atom, as revealed by a sharper distance distribution peak
(cf. λ ) 0v sλ ) 1; Supporting Information, Figure S1b).
The aforementioned ligand carboxyl-Y406 interaction is
destabilized. Moreover, the ligand guanidinium loses its
favorable electrostatic interaction with N1 E277, which shifts
away from the perturbed moiety. However, the ligand
acetamide group is pushed closer to residue R156, which
forms a hydrogen bond with atom OP (data not shown). This
residue is not observed to closely interact with the unper-
turbed PVR molecule.
Following the λ ) 0 f λ ) 1 TAIL1 perturbation, I222
and W178 distance distributions for the modiﬁed PVR
aliphatic tail (C8 and C9 atoms) transition to sharper and
fewer peaks (cf. λ ) 0v sλ ) 1; Supporting Information,
Figure S1c,d). On the other hand, the λ ) 0 f λ ) 1 TAIL2
perturbation has a limited effect, as the distributions of tail
atoms C8 and C10 with I222 and W178 residues remain
predominantly broad (0.4-0.9 nm; Supporting Information,
Figure S1e,f).
Role of Ligand Hydration in N1 Binding Thermody-
namics. Scheme 1 summarizes the hydration free energy for
PVR, ∆G j
hydr, and the changes of this quantity for its
Table 3. Free-Energy Change upon N1-PVR Binding
a
free energy (kJ mol-1)
uncertainties
change σ∆G j
d σ∆G j(%)
e
∆G j
bind
exp b -62.2 1.8 3
∆G j
bind
c -61.1 5.4 9
∆Gbind(N)
f σ∆Gi
g σ∆Gi(%)
i ) 1 -63.7 11.0 17
i ) 2 -55.3 9.0 16
i ) 3 -55.8 10.1 18
i ) 4 -80.6 9.9 12
i ) 5 -50.1 9.7 19
a The average ∆G j
bind
exp value from repeated experiments can be
compared with the IT-TI ∆G j
bind estimate. Corresponding ∆G j
bind(N)
values from individual standard TI trajectories are also reported.
b Derived using data in refs 21, 51, and 52 (see Supporting
Information, Table S4).
c Equation 2.
d Equation 5, with
propagated uncertainties as in eq 6.
e Equation 7.
f Equation 1, N
) 5.
g Equation 4.
IT-TI Free-Energies of H5N1-PVR Inhibition J. Chem. Theory Comput., Vol. 5, No. 4, 2009 1113alchemical modiﬁcations, ∆∆G j
hydr. The corresponding bind-
ing free-energy, ∆G j
bind, and changes of this quantity,
∆∆G j
bind, are also reported. Figure 6 illustrates the relative
components involved for PVR alchemical modiﬁcations.
We estimate an IT-TI ∆G j
hydr value of -107.8 ( 1.2 kJ
mol-1 for the PVR molecule. No experimental data is
available to date for a direct comparison of this result. We
note that this value is in qualitative agreement with hydration
free energies of a large variety of compounds used to
calibrate the force ﬁeld used in this study.
6,7,30 The value of
-820.5 ( 40.2 kJ mol-1 reported based on MM-PBSA
calculations signiﬁcantly overestimates the favorable ther-
modynamic effect of PVR hydration.
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The COO- perturbation gives a positive ∆∆G j
hydr value
of 15.7 ( 5.1 kJ mol-1. The PVR carboxyl group gives
distinct primary and secondary rdf peaks in water. When
deleting its charge, water structure is reduced (λ ) 0v sλ )
1; wt-COO-; Supporting Information, Figure S2). Ligand
hydration around this moiety is maintained in the N1 binding
site, yet its ﬁrst solvation shell is displaced (cf. λ ) 0v sλ
) 1; N1-COO-; Supporting Information, Figure S2). A
sufﬁciently unfavorable ligand hydration free energy in the
unbound state would drive hydrophobic binding. However,
this effect is not large enough to compensate for the loss of
favorable N1-ligand interactions (see the previous section).
The COO- charge perturbation has the largest unfavorable
impact in the N1-bound state, leading to a ∆∆G j
bind value of
55.1 ( 3.1 kJ mol-1.
A different thermodynamic compensation occurs between
the bound and unbound states for the NR3
+ charge perturba-
tion, with a large unfavorable ∆∆G j
hydr value of +124.9 (
1.8 kJ mol-1. The single solvation peak of the PVR
guanidinium group in water shifts to larger distances (cf. λ
) 0v sλ ) 1; wt-NR3
+; Supporting Information, Figure S2)
due to hydrophobic desolvation of this bulky charge group.
The limited hydration of the charged PVR guanidinium in
the N1 active site is almost unaffected by the perturbation
(cf. λ ) 0v sλ ) 1; N1-NR3
+; Supporting Information,
Figure S2). The NR3
+ charge perturbation has the largest
unfavorable impact on the unbound state, overcompensating
for the loss of N1-ligand favorable interactions (see previous
section). This leads to a net ∆∆G j
bind change of -79.7 ( 4.2
kJ mol-1, signiﬁcantly more favorable than the PVR ∆G j
bind
value. The experimentally observed, improved binding of
inhibitors to N2 neuraminidase by hydrophobic substitution
at the PVR guanidinium position supports these results.
53
In water, TAIL1 and TAIL2 modiﬁcations increase the
solvation around the unperturbed atoms (cf. λ ) 0v sλ ) 1;
Supporting Information, Figure S2) and correlate to the
∆∆G j
hydr values of -1.4 ( 0.6 and 7.3 ( 0.3 kJ mol-1,
respectively. In the N1 binding site, a distinct decrease (∼0.5
units) for TAIL1 solvation (C9 atom; Supporting Information,
Figure S2) agrees with the rearrangement of N1 hydrophobic
residues I222 and W178 (see above). The opposite signs of
∆∆G j
hydr offset the changes observed in the protein as well
as entropic changes to the aliphatic tail, resulting in similar
∆∆G j
bind values of -5.8 ( 2.4 and -1.5 ( 2.0 kJ mol-1 for
TAIL1 and TAIL2 alchemical modiﬁcations (Figure 6).
Overall, these results emphasize the dominant electrostatic
contribution to the free energy of N1 binding for PVR and
its alchemically modiﬁed variants and suggest that future
drug development may also be guided by conveniently tuning
ligand ﬂexibility and hydrophobicity.
Conclusion
The independent-trajectories thermodynamic-integration (IT-
TI) approach was presented. It allows for estimation of
improved free-energy changes for biomolecular systems
based on multiple independent simulations. Our results
underscore the improved predictive power of IT-TI vs
standard TI, due to the increased statistical reliability.
Standard TI estimates from individual trajectories span a
rather large free-energy estimate range, from a 19% under-
estimation to a 29% overestimation of the experimental
reference value (-62.2 ( 1.8 kJ mol-1). Remarkably, our
IT-TI binding free-energy estimate (-61.1 ( 5.4 kJ mol-1)
is in excellent agreement, i.e. 2% relative difference. A
general formulation is proposed to evaluate corresponding
IT-TI free-energy uncertainties that rely on a statistical
treatment of error analysis. Overall, IT-TI seems particularly
promising in the case of highly ﬂexible protein receptors,
ligands, and macromolecular binding partners in general.
Using 20-ns molecular dynamics simulation of the N1-
PVR complex, we ﬁnd a number of key binding interactions.
The interactions of the PVR guanidinium group with N1
E277, E227, and E119; the PVR carboxyl group with
catalytic N1 Y406; and the PVR aliphatic tail with N1 W178
and I222 in the hydrophobic subpocket appear most relevant
to drive N1-PVR binding, based on conformational and
hydration analyses. This dynamic, atomistic description was
correlated with key thermodynamic contributions to binding.
Furthermore, IT-TI was applied to explore the binding
determinants of avian inﬂuenza N1 neuraminidase inhibi-
tion using alchemical modiﬁcation of the PVR molecule.
Charge annihilation of its carboxyl and guanidinium
groups has the largest unfavorable impact in the N1-bound
and unbound states, respectively. These results emphasize
Figure 6. Binding free energies (∆∆G j
bind, gray solid bars)
and corresponding hydration free energies (∆∆G j
hydr, diagonal
lined bars) for all modiﬁcation perturbations in this study.
Vertical bars display the corresponding uncertainties σ∆G j.
Corresponding free-energy values and uncertainties can be
found in Scheme 1 and in Supporting Information, Table S3.
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free energy. Alchemical modiﬁcations of the PVR aliphatic
tail suggest that future drug development may also be
guided by conveniently tuning ligand ﬂexibility and
hydrophobicity.
Finally, this study allows us more general conclusions on
free-energy calculations in the context of protein-ligand
binding. The key to designing improved inhibitors for a given
target relies on an accurate thermodynamic description of
both ligand-bound and ligand-unbound receptor and ligand
states. Consequently, we suggest that the most reliable and
predictive free-energy calculations will likely rely on the use
of explicit solvent simulations and MD force ﬁelds based
also on a direct and general parametrization of solvation
thermodynamics. We anticipate the application of the IT-TI
approach to develop improved and potent drugs to inhibit
ﬂexible macromolecular receptors.
Acknowledgment. The authors thank the members of
the McCammon group for useful discussions. This work was
supported, in part, by the National Science Foundation grant
PHY-0822283, Center for Theoretical Biological Physics,
for the computing resources. Additional support has been
provided by NSF, NIH, HHMI, and NBCR.
Supporting Information Available: GROMOS force-
ﬁeld parameters for the PVR molecule, Table S1; summary
of IT-TI calculations, Table S2; summary of the IT-TI free
energies calculated, Table S3; experimental observables used
to estimate N1-PVR binding free energy, Table S4; PVR
distance distributions during modiﬁcation perturbations,
Figure S1; PVR hydration analysis during modiﬁcation
perturbations, Figure S2. This material is available free of
charge via the Internet at http://pubs.acs.org
References
(1) van Gunsteren, W. F.; Beutler, T. C.; Fraternali, F.; King,
P. M.; Mark, A. E.; Smith, P. E. Computation of Free Energy
in Practice: Choice of Approximations and Accuracy
Limiting Factors; ESCOM Science Publishers: Leiden, 1993;
Vol. 2.
(2) Jorgensen, W. L. Science 2004, 303, 1813–1818.
(3) McCammon, J. A. Curr. Opin. Struct. Biol. 1998, 8, 245–
249.
(4) Gilson, M. K.; Zhou, H. X. Annu. ReV. Biophys. Biomol.
Struct. 2007, 36, 21–42.
(5) Beveridge, D. L.; DiCapua, F. M. Annu. ReV. Biophys.
Biophys. Chem. 1989, 18, 431–492.
(6) Baron, R.; Trzesniak, D.; de Vries, A. H.; Elsener, A.; Marrink,
S. J.; van Gunsteren, W. F. ChemPhysChem 2007, 8, 452–
461.
(7) Schuler, L. D.; Daura, X.; van Gunsteren, W. F. J. Comput.
Chem. 2001, 22, 1205–1218.
(8) Lybrand, T. P.; McCammon, J. A.; Wipff, G. Proc. Natl.
Acad. Sci. U.S.A. 1986, 83, 833–835.
(9) Hu ¨nenberger, P. H.; Helms, V.; Narayana, N.; Taylor, S. S.;
McCammon, J. A. Biochemistry 1999, 38, 2358–2366.
(10) Reinhardt, W. P.; Miller, M. A.; Amon, L. M. Acc. Chem.
Res. 2001, 34, 607–614.
(11) Chipot, C.; Pohorille, A. Free Energy Calculations; Springer:
New York, 2007; Vol. 86.
(12) Zagrovic, B.; van Gunsteren, W. F. J. Chem. Theory Comput.
2007, 3, 301–311.
(13) Adcock, S. A.; McCammon, J. A. Chem. ReV. 2006, 106,
1589–1615.
(14) Fujitani, H.; Tanida, Y.; Ito, M.; Jayachandran, G.; Snow,
C. D.; Shirts, M. R.; Sorin, E. J.; Pande, V. S. J. Chem. Phys.
2005, 123, 084108.
(15) Zacharias, M.; Straatsma, T. P.; McCammon, J. A. J. Chem.
Phys. 1994, 100, 9025–9031.
(16) Beutler, T. C.; Mark, A. E.; van Schaik, R. C.; Gerber, P. R.;
van Gunsteren, W. F. Chem. Phys. Lett. 1994, 222, 529–539.
(17) Gilson, M. K.; Given, J. A.; Bush, B. L.; McCammon, J. A.
Biophys. J. 1997, 72, 1047–1069.
(18) Hamelberg, D.; McCammon, J. A. J. Am. Chem. Soc. 2004,
126, 7683–7689.
(19) Skeik, N.; Jabr, F. I. Int. J. Infect. Dis. 2007, 12, 233–238.
(20) Le, Q. M.; Kiso, M.; Someya, K.; Sakai, Y. T.; Nguyen, T. H.;
Nguyen, K. H.; Pham, N. D.; Ngyen, H. H.; Yamada, S.;
Muramoto, Y.; Horimoto, T.; Takada, A.; Goto, H.; Suzuki,
T.; Suzuki, Y.; Kawaoka, Y. Nature 2005, 437, 1108.
(21) Hurt, A. C.; Selleck, P.; Komadina, N.; Shaw, R.; Brown, L.;
Barr, I. G. AntiViral Res. 2007, 73, 228–31.
(22) Chand, P.; Bantia, S.; Kotian, P. L.; El-Kattan, Y.; Lin, T. H.;
Babu, Y. S. Bioorg. Med. Chem. 2005, 13, 4071–4077.
(23) Gubareva, L. V.; Webster, R. G.; Hayden, F. G. Antimicrob.
Agents Chemother. 2001, 45, 3403–3408.
(24) De Clercq, E. Expert Opin. Emerg. Drugs 2008, 13, 393–
416.
(25) Shirts, M.; Pande, V. S. Science 2000, 290, 1903–1904.
(26) Russell, R. J.; Haire, L. F.; Stevens, D. J.; Collins, P. J.; Lin,
Y. P.; Blackburn, G. M.; Hay, A. J.; Gamblin, S. J.; Skehel,
J. J. Nature 2006, 443, 45–49.
(27) Christen, M.; Hu ¨nenberger, P. H.; Bakowies, D.; Baron, R.;
Burgi, R.; Geerke, D. P.; Heinz, T. N.; Kastenholz, M. A.;
Krautler, V.; Oostenbrink, C.; Peter, C.; Trzesniak, D.; van
Gunsteren, W. F. J. Comput. Chem. 2005, 26, 1719–1751.
(28) van Gunsteren, W. F.; Billeter, S. R.; Eising, A. A.; Hu ¨nen-
berger, P. H.; Kruger, P.; Mark, A. E.; Scott, W. R. P.; Tironi,
I. G. Biomolecular Simulation: The GROMOS96 Manual
and User Guide; vdf Hochschulverlag AG an der ETH Zu ¨rich
and BIOMOS b.v. Groningen: Zu ¨rich, Groningen, 1996.
(29) Baron, R.; Bakowies, D.; van Gunsteren, W. F. J. Pept. Sci.
2005, 11, 74–84.
(30) Lins, R. D.; Hu ¨nenberger, P. H. J. Comput. Chem. 2005,
26, 1400–1412.
(31) Berendsen, H. J. C. Interaction Models for Water in Relation
to Protein Hydration; Pullman, B. E., Ed.; Reidel: Dordrecht,
1981.
(32) Åqvist, J. J. Phys. Chem. 1990, 94, 8021–8024.
(33) Hockney, R. W. Methods Comput. Phys. 1970, 9, 136–211.
(34) Ryckaert, J. P.; Ciccotti, G.; Berendsen, H. J. C. J. Comput.
Phys. 1977, 23, 327–341.
(35) Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.;
di Nola, A.; Haak, J. R. J. Chem. Phys. 1984, 81, 3684–
3690.
IT-TI Free-Energies of H5N1-PVR Inhibition J. Chem. Theory Comput., Vol. 5, No. 4, 2009 1115(36) Tironi, I. G.; Sperb, R.; Smith, P. E.; van Gunsteren, W. F.
J. Chem. Phys. 1995, 102, 5451–5459.
(37) Heinz, T. N.; van Gunsteren, W. F.; Hu ¨nenberger, P. H.
J. Chem. Phys. 2001, 115, 1125–1136.
(38) Heinz, T. N.; Hu ¨nenberger, P. H. J. Comput. Chem. 2004,
25, 1474–1486.
(39) McLachlan, A. D. J. Mol. Biol. 1979, 128, 49–79.
(40) Kirkwood, J. G. J. Chem. Phys. 1935, 3, 300–313.
(41) Allen, M. P.; Tildesley, D. J. Computer Simulations of
Liquids; Oxford University Press: New York, 1989.
(42) Taylor, J. R. An Introduction to Error Analysis. The Study
of Uncertainties in Physical Measurements, 2nd ed.;
University Science Books: Sausalito, CA, 1997.
(43) Amaro, R. E.; Minh, D. D.; Cheng, L. S.; Lindstrom, W. M.,
Jr.; Olson, A. J.; Lin, J. H.; Li, W. W.; McCammon, J. A.
J. Am. Chem. Soc. 2007, 129, 7764–7765.
(44) Landon, M. R.; Amaro, R. E.; Baron, R.; Ngan, C. H.;
Ozonoff, D.; McCammon, J. A.; Vajda, S. Chem. Biol. Drug
Des. 2008, 71, 106–116.
(45) Babu, Y. S.; Chand, P.; Bantia, S.; Kotian, P.; Dehghani, A.;
El-Kattan, Y.; Lin, T. H.; Hutchison, T. L.; Elliott, A. J.;
Parker, C. D.; Ananth, S. L.; Horn, L. L.; Laver, G. W.;
Montgomery, J. A. J. Med. Chem. 2000, 43, 3482–3486.
(46) Chachra, R.; Rizzo, R. C. J. Chem. Theory Comput. 2008,
4, 1526–1540.
(47) Yen, H. L.; Hoffmann, E.; Taylor, G.; Scholtissek, C.; Monto,
A. S.; Webster, R. G.; Govorkova, E. A. J. Virol. 2006, 80,
8787–8795.
(48) Malaisree, M.; Rungrotmongkol, T.; Decha, P.; Intharathep,
P.; Aruksakunwong, O.; Hannongbua, S. Proteins 2008, 71,
1908–1918.
(49) Baron, R.; McCammon, J. A. Biochemistry 2007, 46, 10629–
10642.
(50) Clarke, C.; Woods, R. J.; Gluska, J.; Cooper, A.; Nutley,
M. A.; Boons, G. J. J. Am. Chem. Soc. 2001, 123, 12238–
12247.
(51) Cheng, Y.; Prusoff, W. H. Biochem. Pharmacol. 1973, 22,
3099–3108.
(52) Collins, P. J.; Haire, L. F.; Lin, Y. P.; Liu, J.; Russell, R. J.;
Walker, P. A.; Skehel, J. J.; Martin, S. R.; Hay, A. J.; Gamblin,
S. J. Nature 2008, 453, 1258–1261.
(53) Maring, C. J.; Stoll, V. S.; Zhao, C.; Sun, M.; Krueger, A. C.;
Stewart, K. D.; Madigan, D. L.; Kati, W. M.; Xu, Y.; Carrick,
R. J.; Montgomery, D. A.; Kempf-Grote, A.; Marsh, K. C.;
Molla, A.; Steffy, K. R.; Sham, H. L.; Laver, W. G.; Gu,
Y. G.; Kempf, D. J.; Kohlbrenner, W. E. J. Med. Chem. 2005,
48, 3980–3990.
CT800559D
1116 J. Chem. Theory Comput., Vol. 5, No. 4, 2009 Lawrenz et al.